All three AD enriched subtypes exhibited CSF biomarker profiles typical of AD, characterized by high levels of CSF total tau and pTau, lower Aβ, and lower MoCA scores (Supplemental Tables 13–14). The gene discussed is MAPT; the disease is Alzheimer disease.